# Exicure, Inc. (XCUR) · Edgar & Edgarette company card

> Exicure (XCUR) saw revenue fall 100% in FY2025 to $0 million, operating margin null against a -3.8% median for pharmaceutical preparations, equity 28.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1698530 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/XCUR) · [JSON](https://www.pops4.com/boards/company/XCUR.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $0 |
| Revenue growth, 1 year | -100.0% |
| Revenue growth per year | — |
| Operating margin | -Infinity% (prior year -2446.4%) |
| Net margin | -Infinity% |
| Operating cash flow | −$9M |
| Capital spending | $1,000 |
| Free cash flow | −$9M |
| Cash | $4M |
| Long-term debt | — |
| Total assets | $14M |
| Total equity | $4M |
| Equity ÷ assets | 28.0% |
| Return on equity | -126.0% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -48.69 (distress zone)
- Piotroski F: 2 of 9 (weak)
- Health Harbor boat: Old boat · three warning signs · filed late quarterly report notice in the last 12 months; operating cash flow was negative (-$8.6M in FY2025); operating loss: a margin of -Infinity% in FY2025

## Edgarette's reading

Exposure: revenue $0K (FY2025). Experience: revenue down 100.0% on the year; operating margin null, down from -2446.4%. Soundness: equity 28.0% of assets, return on equity -126.0%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $0K and $0K next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin null against a -3.8% median; growth -100.0% against 13.7%.

Range logged 2026-09-20, receipt 88605ed5c6753642, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-09-16 ([filing](https://www.sec.gov/Archives/edgar/data/1698530/000119312526392654/0001193125-26-392654-index.htm))
- Item NT 10-Q Late quarterly report notice: 1, latest 2026-05-15 ([filing](https://www.sec.gov/Archives/edgar/data/1698530/000169853026000044/0001698530-26-000044-index.htm))
- Item 5.02 Director or officer change: 5, latest 2026-06-30 ([filing](https://www.sec.gov/Archives/edgar/data/1698530/000119312526290264/0001193125-26-290264-index.htm))

## Recent filings

- 8-K · filed 2026-09-16 · 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule · [filing](https://www.sec.gov/Archives/edgar/data/1698530/000119312526392654/0001193125-26-392654-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/1698530/000119312526352011/0001193125-26-352011-index.htm)
- 8-K · filed 2026-06-30 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1698530/000119312526290264/0001193125-26-290264-index.htm)
- 8-K · filed 2026-06-01 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1698530/000169853026000060/0001698530-26-000060-index.htm)
- 10-Q · filed 2026-05-29 · [filing](https://www.sec.gov/Archives/edgar/data/1698530/000169853026000057/0001698530-26-000057-index.htm)
- 8-K · filed 2026-04-10 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1698530/000169853026000036/0001698530-26-000036-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001698530.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1698530

## Cite

POPS4, Edgar & Edgarette: Exicure, Inc. (XCUR) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/XCUR. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.